Try For Free 7-Day Free Trial
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
|Overall||64 of 64|
|Sector (Technology Hardware)||1 of 1|
|Type (Growth Capital)||22 of 22|
|State (New Jersey)||7 of 7|
|Country (United States)||56 of 56|
|Year (2022)||3 of 3|
Christchurch , New Zealand
Syft develops SIFT-MS, a form of direct mass spectrometry that analyses volatile organic compounds (VOCs) in the air with typical detection limits at parts-per-trillion level (by volume; pptv). Syft was founded in 2002 and is based in Christchurch, New Zealand.